Main Article Content

Abstract

AmbroxolHCl is a drug that breaks up phlegm, used in the treatment of respiratory diseases associated with viscid or excessive mucus. Ambroxol is often administered as an active ingredient in cough syrup. Present work aimed at preparing quick onset of action which is beneficial in respiratory diseases, aiding in the enhancement of bioavailabity and is very convenient for administration without the problem of swallowing and using water.  The film was prepared by using polymers such asHPMC,HPMC K100 and HPMC K1500by a solvent casting method.  They wereevaluated for physical characteristics such as Thickness, Weight Variation, Disintegration time, Drug content, Tensile strength, % Elongation, Folding Endurance and Invitro Dissolution Studies give satisfactory results. The in vitro dissolution time of the optimized batch F4 was found to be 98.97 %.  The optimized batchin vitro disintegration time was found to 14 to 22 sec.

Keywords

AmbroxolHCl, HPMC,HPMC K100 and HPMC K1500 and solvent casting method.

Article Details

How to Cite
Manoj Bag, Mithun Bhowmick, Pritam Saha, & Pratibha Bhowmick. (2023). Formulation and in-vitro evaluation of Mucolytic Fast Dissolving Oral Film Containing Ambroxol HCL using various polymers. International Journal of Research in Pharmacology & Pharmacotherapeutics, 12(2), 98-106. https://doi.org/10.61096/ijrpp.v12.iss2.2023.98-106

References

  1. 1. BalaR, PawarP, KhannaS, AroraS. Orally dissolving strips: A new approach to oral drug delivery system. Int J Pharm Investig.2013Apr-Jun;3(2):67-76. doi: 10.4103/2230-973X.114897, PMID 24015378.
  2. 2. Siddiqui MD, Garg G, Sharma P. A short review on ”A Novel Approach in Oral Fast Dissolving Drug Delivery System and their Patents”.AdvBiolRes.2011;5:291-303.
  3. 3. Galey WR, Lonsdale HK, Nacht S. The in vitro permeability of skin and buccal mucosa to selected drugs and tritiated water.J Invest Dermatol.1976;67(6):713-7. doi: 10.1111/1523-1747.ep12598596, PMID 1033956.
  4. 4. Shidhaye S, Kadam V, Malke S. Formulation and evaluation of oxcarbazepine fast dissolve tablets. Indian J Pharm Sci.2007;69(2):211-4. doi: 10.4103/0250-474X.33145.
  5. 5. Mishra R, Amin A. Formulation and characterization of rapidly dissolving films of cetirizine hydrochloride using pullulan as a film forming agent. Indian J Pharm EducRes.2011;45:71-7.
  6. 6. Mahajan A, Chabra N, Aggarwal G. Formulation and characterization of fast dissolving buccal films: a review. Sch Res Libr.Pharm Lett.2011;3:152-65.
  7. 7. Chemical marketreporter. Fuisz sign deal for drug delivery. Chem Mark Report.1998;253:17.
  8. 8. MahboobMBH, RiazT, JamshaidM, BashirI, ZulfiqarS. Oral films: A comprehensivereview. IntCurrPharmJ.Nov2016;5(12):111-7. doi: 10.3329/icpj.v5i12.30413.
  9. 9. ManivannanR. Oral disintegrating tablets: A future compaction. Drug Invent Today. 2009;1(1):61-5.
  10. 10. SiddiquiMN, GargG, SharmaPK. A short review on-a novel approach in oral fast dissolving drug delivery system and their patents.AdvBiolRes. 2011;5(6):291-303.
  11. 11. Fulzele SV, Satturwar PM, Dorle AK. Polymerized rosin: novel film forming polymer for drug delivery. Int J Pharm.2002;249(1-2):175-84. doi: 10.1016/s0378-5173(02)00529-x, PMID 12433446.
  12. 12. BarnhartS, SlobodaM. Dissolvable films the future of dissolvable films. Drug DevTech. 2007a;1:34-5.
  13. 13. MeathrelB, MoritzC. Dissolvable films and their potential in ivds. IVD Technol. 2007;13(9):53-8.
  14. 14. Dixit RP, Puthli SP. Oral strip technology: overview and future potential. J Control Release.2009;139(2):94-107. doi: 10.1016/j.jconrel.2009.06.014, PMID 19559740.
  15. 15. KulkarniN, KumarL, SorgA. Fast dissolving orally consumable films containing an antitussive and a mucosa coating agent. Google patents; 2003.
  16. 16. HariharanM, BogueA. Orally dissolving film strips (odfs): the final evolution of orally dissolving dosage forms. Drug Deliv Technol. 2009;9(2):24-9.
  17. 17. SohiH, SultanaY, KharRK. Taste masking technologies in oral pharmaceuticals: recent developments and approaches. Drug DevIndPharm. 2004;30(5):429-48. doi: 10.1081/ddc-120037477, PMID 15244079.
  18. 18. Franchiser, Slominski C, G, MeyerS;2007. Disintegrable oral films.US Patent202057.
  19. 19. LydzinskiS, ManegoldT, SolarekD, TsaiJ, PuglisiC. Oral film which contains starch as main component; useful for delivering a variety of agents to humans and other animals. Google patents; 2002.
  20. 20. BankerGS. Film coating theory and practice.J PharmSci. 1966;55(1):81-9. doi: 10.1002/jps.2600550118, PMID 5918657.